Design and Applications of Next-Generation Antibody Technologies and Therapies

March 12-13 (Ventura, California)

• "Fc Gamma Receptor Promotion of Antibody-Induced LILRB4 Internalization and Immune Regulation of Acute Monocytic Leukemia
• "Antibody-Lectin Bispecifics for Glyco-Immune Checkpoint Blockade"

Drug Carriers in Medicine and Biology

-July 31-August 5^th (West Dover, Vermont)

• Advances Toward Translation and Carrier Interactions with the Immune System
• Intracellular Delivery of Biologics

https://www.grc.org/

Link: https://www.toxicology.org/

March 27-31, 2022

San Diego California

Special interest group: Immunotoxicology specialty section

Courses: Conceptual Models in Immunotoxicology: Leveraging Biological Knowledge, Alternative Approaches, and Computational Strategies for the Future of Risk Assessment

November 13–16, 2022

Denver Colorado

Link: https://www.actox.org/

May 6-10 2022

Portland Oregon

Session of interest:

1. Immunomodulation and Immunotherapy: Lessons to Improve Health

Link: https://www.aai.org/

TBA

Link: https://www.hematology.org/

Annual meeting: June 21-24^th 2022

San Francisco

Link: https://www.focisnet.org/

April 8^th -13^th 2022

New Orleans, Louisana

Sessions and Symposia  of interest:

1. Precision Medicine for Immuno-oncology and the Promise for the Future
2. Clinical Progress with CD3 Bispecifics
3. Immunoprevention and Clinical Trials
4. Immunotherapy for Solid Tumors and Blood Cancers in Adult and Pediatric Patients
5. Myeloid Targets to Enhance Therapeutic Antitumor Immunity
6. Nerves, Cancer, and Immunity
7. Radiation and Immunotherapy
8. Adjuvant versus Neoadjuvant Immunotherapy
9. New Developments in Immunotherapy: Targeting Cytokines
10. Next-Generation Costimulatory Receptor Agonists in Combination with CD3 Bispecific Antibodies

Educational Sessions:

• Chemistry to the Clinic: Part 2 of 3: Progress in Small Molecule Cancer Immunology Therapy
• Diet, Microbiota, and Cancer Immunotherapies
• Metabolism, Inflammation, and Immunotherapy
• Next Frontiers in Neoadjuvant Immunotherapy: Diversification and Durability of the Immune Response
• Predictive Biomarkers for Immunotherapy
• Tumor Immunology and Immunotherapy for Nonimmunologists: The Immunological Bases of Durable Responses to Cancer Immunotherapy

Link: https://www.aacr.org/

September 10-13 2023

Ljubljana Slovenia

Theme “Toxicology- multidisciplinary science leading to safer and sustainable life”

Link: https://www.eurotox.com/

September 12-13 2022

School of Pharmaceutical Sciences, Health Sciences University of Hokkaido

Theme: The relationship between innate immunity and acquired immunity and immunotoxicity

Link: http://www.immunotox.org/english/

November 8^th – November 12^th Boston MA

Link: https://www.sitcancer.org/home

41^st Annual Symposium “ Toxicologic Pathology of the Hematopoietic System”

 June 18-23 2022 Austin Texas

Session of interest:

1. From Anticipated Immunomodulation to Safety Concern: Use of Immune Biomarkers in Preclinical Studies
2. Current Topics in Hematopoietic Neoplasms and Clonal Diseases

Link: https://www.toxpath.org/

Bioanalysis -Biomarkers-Immunogenicity -Gene Therapy -Cell Therapy -Vaccines 

Date: September 26-30, 2022 in Atlanta, GA, USA

Full-Day Specialized Workshop of interest:

Advanced Immunogenicity Testing & Reporting of Biotherapeutics:

New FDA Draft Guidance on Prescription Drug Labeling; Harmonization of Regulations; Enhanced Cut points Approaches; Preclinical & Clinical Assessment and Clinical Relevance; Risk-based Approaches, Prediction and Mitigation; Problem Solving for Complex NAb Assays

Link: https://www.wrib.org/